Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.

[1]  J. Verhagen,et al.  Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan , 1985, FEBS letters.

[2]  B. Vargaftig,et al.  INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021 , 1985, The Lancet.

[3]  G. Hunninghake,et al.  Late asthmatic responses: Inquiry into mechanisms and significance , 1985, Clinical reviews in allergy.

[4]  A. Kay,et al.  Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils. , 1984, Clinical and experimental immunology.

[5]  C. Dahlgren,et al.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes , 1984, Infection and immunity.

[6]  J. Vliegenthart,et al.  Specific leukotriene formation by purified human eosinophils and neutrophils , 1984 .

[7]  D. Wakefield,et al.  Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes , 1984, Infection and immunity.

[8]  P. Walstra,et al.  Separation and quantitation of leukotrienes by reversed-phase high-performance liquid chromatography. , 1984, Prostaglandins, leukotrienes, and medicine.

[9]  H. Kauffman,et al.  Plasma histamine concentrations and complement activation during house dust mite‐provoked bronchia] obstructive reactions , 1983, Clinical allergy.

[10]  E. Goetzl,et al.  Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. , 1982, Clinical and experimental immunology.

[11]  A. Capron,et al.  Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor , 1981, Nature.

[12]  J. Benveniste,et al.  Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosis , 1980, European journal of clinical investigation.

[13]  D. Loegering,et al.  Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.

[14]  R. Davies,et al.  Recurrent nocturnal asthmatic reactions to bronchial provocation tests , 1979, Clinical allergy.

[15]  A. Kay,et al.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors , 1977, Nature.

[16]  H. Sluiter,et al.  Late bronchial obstructive reaction to experimental inhalation of house dust extract , 1972, Clinical allergy.

[17]  K. de Vries,et al.  Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. , 1971, The Journal of allergy and clinical immunology.